Screening for prostate cancer: time to put all the data on the table

Ian Haines and colleagues call for access to all the publicly funded clinical trial data from two major trials to settle the controversies around screening for prostate cancer with prostate specific antigen

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ (Online) 2016-05, Vol.353, p.i2574-i2574
Hauptverfasser:	Haines, Ian E, Ablin, Richard J, Miklos, George L Gabor
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Australia - epidemiology Cost-Benefit Analysis Early Detection of Cancer - economics Early Detection of Cancer - methods Early Detection of Cancer - utilization Humans Male Mass Screening - economics Mass Screening - utilization Middle Aged New Zealand - epidemiology Practice Guidelines as Topic Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - diagnosis Prostatic Neoplasms - economics Prostatic Neoplasms - epidemiology Randomized Controlled Trials as Topic Risk Assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Ian Haines and colleagues call for access to all the publicly funded clinical trial data from two major trials to settle the controversies around screening for prostate cancer with prostate specific antigen
ISSN:	1756-1833 1756-1833
DOI:	10.1136/bmj.i2574